【LMLB152 -灵麦专题报告】-不孕症专题 Lingmed indication report- Infertility

来源: 灵麦医药/Lingmed

欢迎分享,转载有版权, 快快登录 lingmed.net/reports 获取更多项目信息吧!

灵麦医药系列专题报告又如期而至。我们将会针对热门适应症领域,进行深入分析。今天我们来谈谈女性不孕症的全球及中国市场竞争格局。

不孕症是指有正常性生活、未采取避孕措施1~2年尚未受孕或未能生育者,其发病率呈明显上升趋势,世界卫生组织于20世纪80年代中末期在25个国家的33个中心调查结果显示发达国家约有5%~8%的夫妇受到不孕症的影响,发展中国家一些地区不孕症的患病率可高达30%,中国约为6%~15%。全世界的不孕患者人数约为8000万~1.1亿。不孕症发病率的递增趋势可能与晚婚晚育、人工流产、性传播疾病等相关。


EPI流行病学数据及预测

根据WHO数据,90年代后全球大约有10%-20%的不孕症患者。发达国家据调查估计已增至20%-25%。而随着近年来生活节奏加快、工作压力增加、环境恶化、饮食结构改变等因素,中国的不孕症患者人数也在不断增长中。


想要下载完整报告或对其它治疗领域感兴趣?

速速点击文末‘阅读原文’下载吧!


Lingmed Indication report- Infertility
Here comes the Lingmed indication series report! Lingmed will share a series of market analysis report targeting on hot indication areas. We will start with female infertility this week.


Infertility refers to those who has normal sexual life, did not take contraceptive methods but has not yet been conceivedor failed to fertility for  1~2 years. Its incidence is obviously keeps rising. The research did by the World Health Organization (WHO) in the late 1980s among 33 centers in 25 countries showed that in developed countries, about 5%~8% of couples affected by infertility, while in developing countries, the incidence can reach up to 30%. In China, it is about 6%~15%. The world is about 80million - 110 million in the number of infertility. Increased the incidence of infertility may be related to late childbirth of marry at amature age, abortion, and sexually transmitted diseases.

Epidemiology data and forecast 

According to the WHO, there is about 10% - 20% of infertility patients around the world after the 90s. In developed countries, it has been increased to 20%-25% according to the survey estimated. With the quickening pace of life, work pressure increases in recent years, environmental degradation, factors such as diet structure changes, there was a steady increase in numbers of infertility patients in China.


If you are interested in the full report or any other indication area, please click 'read more' to download. 


灵麦医药是以下两家情报数据库在中国的独家合作伙伴:

Biotechgate/博谷 - 全球创新药和器械产品收购和引进数据库

EvaluatePharma/预估医药 - 全球医药研发、销售、市场预估等竞争情报数据库

想要下载完整报告? 

请登录 www.lingmed.net/reports

或点击下方“阅读原文”马上下载